Shedding light on the asparaginase galaxy

In this issue of Blood , Tong et al have reported that therapeutic drug monitoring (TDM) of asparaginase (ASP) activity levels in plasma may be an important tool for the optimization of its therapeutic effects in pediatric acute lymphoblastic leukemia (ALL).[1][1] ![Figure][2] Serum